葛兰素史克称肺癌药在华试验延长生存期
2026-07-10 12:07:13
据彭博社报道，葛兰素史克(GSK Plc)与翰森制药集团合作开发的一款实验性药物，在中国开展的晚期试验中帮助小细胞肺癌患者延长生存期。
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
加拿大皇家银行：美元指数年底或升至104
